US2006008479A1PendingUtilityA1
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
Est. expiryApr 1, 2016(expired)· nominal 20-yr term from priority
A61K 38/00A61K 39/0005G01N 2333/82G01N 2333/71C07K 14/71G01N 33/57585G01N 33/57557A61K 39/001193A61K 39/001106A61K 39/0011A61K 39/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions to elicit or enhance immunity in humans against self tumor antigens are disclosed. Such immunity is generated by immunization with homologous foreign proteins. Self tumor antigens include protein expression products of overexpressed human oncogenes, such as human HER- 2 /neu protein, and organ-specific or tissue-specific differentiation antigens, such as PAP or PSA, associated with tumor cells.
Claims
exact text as granted — not AI-modified1 - 12 . (canceled)
13 . A method of eliciting or enhancing a T cell response to human HER-2/neu protein, comprising immunizing a human being with a composition comprising a protein or portion thereof having at least 80% amino acid sequence homology to HER-2/neu protein but not identical in amino acid sequence to human HER-2/neu protein.
14 . The method of claim 13 wherein the composition further includes a pharmaceutically acceptable carrier or diluent.
15 . The method of claim 13 wherein the composition further includes an adjuvant.
16 . The method of claim 13 wherein the composition further includes an adjuvant and a pharmaceutically acceptable carrier or diluent.Join the waitlist — get patent alerts
Track US2006008479A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.